An Open-Label, Multicenter, Randomized, Non-Inferiority Study to Evaluate the Safety and Effectiveness of Group vs. Individual MDMA-Assisted Therapy in PTSD Patients Diagnosed Following the Events of October 7, 2023
Phase: PHASE2 | Sponsor: Sheba Medical Center | Compound: MDMA
- Status
- recruiting
- Institution
- Sheba Medical Center
- Start date
- 2025-12-24
- End date
- 2029-03-31
- Registry ID
- NCT07469098
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.